Kenota Health
Ruth Abdulmassih possesses extensive leadership experience across multiple sectors including healthcare, diagnostics, and laboratory services. Currently serving on the Board of Directors at Kenota Health since February 2022, Ruth has a strong background as President and CEO of BioTouch, where responsibilities included advancing technological solutions for healthcare logistics. Prior to that, Ruth held the role of CEO at Alternative Biomedical Solutions, focusing on toxicology testing solutions. Ruth’s long tenure at Stericycle included various executive roles, culminating in Executive Vice President, where strategic initiatives drove significant business growth and operational improvements. Early in Ruth's career at Abbott Laboratories, recognition for outstanding sales performance led to increasingly responsible positions, shaping a solid foundation in business management and strategy. Ruth Abdulmassih holds a B.A. in Business and Marketing from Northwood University.
This person is not in any teams
This person is not in any offices
Kenota Health
1 followers
Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.